摘要: The human immunodeficiency retrovirus (HIV), recognized widely as the causative agent of AIDS, was discovered over 25 years ago and is one most highly studied viruses all time. In 1980s through mid 1990s, only a few treatment options were available contracting this virus usually resulted in death. Since introduction mid-1990s HAART (Highly Active Anti-Retroviral Therapy), disease has become manageable for many people who can tolerate new drugs (1, 2). This review article will describe way that works highlight points intervention small molecules have been developed to stop from replicating.
sci-hub.st 参考文章(26)
Tom Matthews, Miklos Salgo, Michael Greenberg, Jain Chung, Ralph DeMasi, Dani Bolognesi, Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes Nature Reviews Drug Discovery. ,vol. 3, pp. 215- 225 ,(2004) , 10.1038/NRD1331
D J Hazuda, P J Felock, J C Hastings, B Pramanik, A L Wolfe, Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase. Journal of Virology. ,vol. 71, pp. 7005- 7011 ,(1997) , 10.1128/JVI.71.9.7005-7011.1997
N. E. Kohl, E. A. Emini, W. A. Schleif, L. J. Davis, J. C. Heimbach, R. A. Dixon, E. M. Scolnick, I. S. Sigal, Active human immunodeficiency virus protease is required for viral infectivity. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 85, pp. 4686- 4690 ,(1988) , 10.1073/PNAS.85.13.4686
Robert C. Gallo, Luc Montagnier, The discovery of HIV as the cause of AIDS. The New England Journal of Medicine. ,vol. 349, pp. 2283- 2285 ,(2003) , 10.1056/NEJMP038194
Arun K. Ghosh, Bruno D. Chapsal, Irene T. Weber, Hiroaki Mitsuya, Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance. Accounts of Chemical Research. ,vol. 41, pp. 78- 86 ,(2008) , 10.1021/AR7001232
Erik De Clercq, Antiviral drugs in current clinical use. Journal of Clinical Virology. ,vol. 30, pp. 115- 133 ,(2004) , 10.1016/J.JCV.2004.02.009
Zhijian Zhao, Scott E Wolkenberg, Meiqing Lu, Vandna Munshi, Gregory Moyer, Meizhen Feng, Anthony V Carella, Linda T Ecto, Lori J Gabryelski, Ming-Tain Lai, Sridar G Prasad, Youwei Yan, Georgia B McGaughey, Michael D Miller, Craig W Lindsley, George D Hartman, Joseph P Vacca, Theresa M Williams, None, Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs). Bioorganic & Medicinal Chemistry Letters. ,vol. 18, pp. 554- 559 ,(2008) , 10.1016/J.BMCL.2007.11.085
A. Parrill, HIV-1 integrase inhibition: binding sites, structure activity relationships and future perspectives. Current Medicinal Chemistry. ,vol. 10, pp. 1811- 1824 ,(2003) , 10.2174/0929867033457043
Claude Fortin, Véronique Joly, Patrick Yeni, Emerging reverse transcriptase inhibitors for the treatment of HIV infection in adults. Expert Opinion on Emerging Drugs. ,vol. 11, pp. 217- 230 ,(2006) , 10.1517/14728214.11.2.217
Neville Anthony, HIV-1 integrase: a target for new AIDS chemotherapeutics. Current Topics in Medicinal Chemistry. ,vol. 4, pp. 979- 990 ,(2004) , 10.2174/1568026043388448